These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1053 related articles for article (PubMed ID: 30968336)

  • 1. Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis.
    Langworthy MJ; Conaghan PG; Ruane JJ; Kivitz AJ; Lufkin J; Cinar A; Kelley SD
    Adv Ther; 2019 Jun; 36(6):1398-1411. PubMed ID: 30968336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Treatment Effect of Triamcinolone Acetonide Extended-Release in Patients with Concordant Baseline Pain Scores on the Average Daily Pain and Western Ontario and McMaster Universities Osteoarthritis Index Pain Scales.
    Ross E; Katz NP; Conaghan PG; Kivitz A; Turk DC; Spitzer AI; Jones DG; Lanier RK; Cinar A; Lufkin J; Kelley SD
    Pain Ther; 2022 Mar; 11(1):289-302. PubMed ID: 34791634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study.
    Conaghan PG; Hunter DJ; Cohen SB; Kraus VB; Berenbaum F; Lieberman JR; Jones DG; Spitzer AI; Jevsevar DS; Katz NP; Burgess DJ; Lufkin J; Johnson JR; Bodick N;
    J Bone Joint Surg Am; 2018 Apr; 100(8):666-677. PubMed ID: 29664853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study.
    Russell SJ; Sala R; Conaghan PG; Habib G; Vo Q; Manning R; Kivitz A; Davis Y; Lufkin J; Johnson JR; Kelley S; Bodick N
    Rheumatology (Oxford); 2018 Dec; 57(12):2235-2241. PubMed ID: 30203101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized Study.
    Hanson P; Kivitz A; Mehra P; Kwong L; Cinar A; Lufkin J; Kelley SD
    Drugs R D; 2021 Sep; 21(3):285-293. PubMed ID: 34350546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical Trials.
    Kivitz AJ; Conaghan PG; Cinar A; Lufkin J; Kelley SD
    Pain Ther; 2019 Dec; 8(2):271-280. PubMed ID: 31066021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA).
    Kraus VB; Conaghan PG; Aazami HA; Mehra P; Kivitz AJ; Lufkin J; Hauben J; Johnson JR; Bodick N
    Osteoarthritis Cartilage; 2018 Jan; 26(1):34-42. PubMed ID: 29024802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial.
    Petrella RJ; Emans PJ; Alleyne J; Dellaert F; Gill DP; Maroney M
    BMC Musculoskelet Disord; 2015 Mar; 16():57. PubMed ID: 25887932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial.
    Bodick N; Lufkin J; Willwerth C; Kumar A; Bolognese J; Schoonmaker C; Ballal R; Hunter D; Clayman M
    J Bone Joint Surg Am; 2015 Jun; 97(11):877-88. PubMed ID: 26041848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of intra-articular triamcinolone acetonide 10 mg vs. 40 mg in patients with knee osteoarthritis: a non-inferiority, randomized, controlled, double-blind, multicenter study.
    Utamawatin K; Phruetthiphat OA; Apinyankul R; Chaiamnuay S
    BMC Musculoskelet Disord; 2023 Feb; 24(1):92. PubMed ID: 36737698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee.
    Paik J; Duggan ST; Keam SJ
    Drugs; 2019 Mar; 79(4):455-462. PubMed ID: 30847805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolone acetonide into both knees of patients with bilateral knee osteoarthritis.
    Kivitz A; Kwong L; Shlotzhauer T; Lufkin J; Cinar A; Kelley S
    Ther Adv Musculoskelet Dis; 2019; 11():1759720X19881309. PubMed ID: 31662801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraarticular Injection of a Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Trial.
    Hangody L; Szody R; Lukasik P; Zgadzaj W; Lénárt E; Dokoupilova E; Bichovsk D; Berta A; Vasarhelyi G; Ficzere A; Hangody G; Stevens G; Szendroi M
    Cartilage; 2018 Jul; 9(3):276-283. PubMed ID: 28535076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Knee Osteoarthritis Treated With an Autologous Protein Solution Injection: A 1-Year Pilot Double-Blinded Randomized Controlled Trial.
    Kon E; Engebretsen L; Verdonk P; Nehrer S; Filardo G
    Am J Sports Med; 2018 Jan; 46(1):171-180. PubMed ID: 29016185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial.
    Raynauld JP; Buckland-Wright C; Ward R; Choquette D; Haraoui B; Martel-Pelletier J; Uthman I; Khy V; Tremblay JL; Bertrand C; Pelletier JP
    Arthritis Rheum; 2003 Feb; 48(2):370-7. PubMed ID: 12571845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Repeat Administration of Triamcinolone Acetonide Extended-release in Osteoarthritis of the Knee: A Phase 3b, Open-label Study.
    Spitzer AI; Richmond JC; Kraus VB; Gomoll A; Jones DG; Huffman KM; Peterfy C; Cinar A; Lufkin J; Kelley SD
    Rheumatol Ther; 2019 Mar; 6(1):109-124. PubMed ID: 30741382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-articular autologous conditioned serum and triamcinolone injections in patients with knee osteoarthritis: a controlled, randomized, double-blind study.
    Damjanov N; Zekovic A
    J Int Med Res; 2023 Oct; 51(10):3000605231203851. PubMed ID: 37818751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of intra-articular injection of tropomyosin receptor kinase A inhibitor in painful knee osteoarthritis: a randomized, double-blind and placebo-controlled study.
    Krupka E; Jiang GL; Jan C
    Osteoarthritis Cartilage; 2019 Nov; 27(11):1599-1607. PubMed ID: 31351965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief Report: A Phase IIb Trial of a Novel Extended-Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis.
    Conaghan PG; Cohen SB; Berenbaum F; Lufkin J; Johnson JR; Bodick N
    Arthritis Rheumatol; 2018 Feb; 70(2):204-211. PubMed ID: 29088579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.